{"id":809213,"date":"2025-02-05T09:21:03","date_gmt":"2025-02-05T14:21:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/"},"modified":"2025-02-05T09:21:03","modified_gmt":"2025-02-05T14:21:03","slug":"fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/","title":{"rendered":"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates"},"content":{"rendered":"<h2>\nFibroBiologics to also present at the BIO CEO &amp; Investor Conference<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">HOUSTON, Feb.  05, 2025  (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (&#8220;FibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it will host an in-person analyst day at the New York Marriott Marquis on February 12, 2025, at 2:00 p.m. ET.<\/p>\n<p>The event will feature presentations from the following members of the Company&#8217;s management:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Pete O\u2019Heeron, Chief Executive Officer<\/li>\n<li style=\"margin-bottom:8pt\">Hamid Khoja, PhD, Chief Scientific Officer<\/li>\n<li style=\"margin-bottom:8pt\">Robert Hoffman, Interim Chief Financial Officer<\/li>\n<\/ul>\n<p align=\"justify\">The event will highlight FibroBiologics\u2019 research and development strategy for advancing fibroblast-based therapeutics to address chronic diseases.<\/p>\n<p align=\"justify\">A live Q&amp;A session will follow the formal presentations. An audio recording of the presentation and Q&amp;A will be available under the investor section of the FibroBiologics website after the event.<\/p>\n<p align=\"justify\">In addition, FibroBiologics will be presenting at the 2025 BIO CEO &amp; Investor Conference in New York, NY, from February 10-11. Details of the event are as follows:<\/p>\n<p>\n        <strong>Date:<\/strong> Tuesday, February 11<br \/><strong>Time: <\/strong>11:15 a.m. ET<br \/><strong>Location: <\/strong>The New York Marriott Marquis<br \/><strong>Track: <\/strong>Plymouth Room<\/p>\n<p>To learn more about the event, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v7Kn14VqrJsLLqjIWzViKixXlewWhkoEYGNvVU_obohc0NiQYMYjHzawJYt76y8lwk8erZbuC8dHBzZqVNBvOxVTpHyavZp7bE4gdYiOcAQ=\" rel=\"nofollow\" target=\"_blank\">https:\/\/bcic.bio.org\/<\/a>, or to schedule one-on-one meetings, please email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N9hP2rwNSQiTOy-ZSpg1XuCKpNukBLo8o_Y1c4EoEiIhYEa8dTAG0HZk0GgwrDn7VIizSjRcIwyCuMEtEZPQuQsah8EFuidVp7zUq9hFXB9l7E8dwhgJ7hbi2VVPoxqt\" rel=\"nofollow\" target=\"_blank\">FibroBiologicsIR@russopr.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About FibroBiologics<\/strong>\n      <\/p>\n<p>Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 160+ US and internationally issued patents\/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Uj6RKAk3Mw4ydkMMjwu60uk5C7O_Vm6bDr64GQewV32CReAf4saQdHA1K5iTOaEPjyRghc1SW-oL8AFUx67XzyKikTQx5aYIsDZHC3Fs1bg=\" rel=\"nofollow\" target=\"_blank\">www.FibroBiologics.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>General Inquiries:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FWK_6q13hx3d8QkdH7sWuUOZG3Bv1ckjv_8n51qe4dGqlqxpBKBYKakwLUyAx2XRQTaOkFlMxwWhasx-lG6pI0Ng1PIf3eYD8YA_Lodrquo=\" rel=\"nofollow\" target=\"_blank\">info@fibrobiologics.com<\/a>\n      <\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Nic Johnson <br \/>Russo Partners<br \/>(212) 845-4242<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0d8trduKnHKUpOaLW7tQx7zAXFdbU7LUcd-q6RXMzICPLLSE_EOdcC9w7NIZvzC58i6hybeRjeb7rMSWEbFuDOX6MzpAZZoi5UgPN_jMZUr31enpLui8fbsGUrz9iFUr\" rel=\"nofollow\" target=\"_blank\">fibrobiologicsIR@russopr.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Liz Phillips<br \/>Russo Partners<br \/>(347) 956-7697<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MhPUnhmvW4r2T_Rwd08Bdfsi3wpvQVhHaPTdr6YyWmlM-EQLiUakqjqJI-ivtza4RjN0_izuGnP37zyxQ3u3iVeOg9ZL5dJQvUxRUxBxJfsmMBDMjM18CDC2K0IU9gmIolhzhs5cq-WkdXNnmf3adg==\" rel=\"nofollow\" target=\"_blank\">Elizabeth.phillips@russopartnersllc.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzU1N2E1ZDMtOGZiYS00OTkwLWIwNWUtMDkyNzQ1OTJjYTczLTEyNzUwODE=\/tiny\/Fibrobiologics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FibroBiologics to also present at the BIO CEO &amp; Investor Conference HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (&#8220;FibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it will host an in-person analyst day at the New York Marriott Marquis on February 12, 2025, at 2:00 p.m. ET. The event will feature presentations from the following members of the Company&#8217;s management: Pete O\u2019Heeron, Chief Executive Officer Hamid Khoja, PhD, Chief Scientific Officer Robert Hoffman, Interim Chief Financial Officer The event will highlight FibroBiologics\u2019 research and development strategy for advancing fibroblast-based therapeutics to address &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-809213","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FibroBiologics to also present at the BIO CEO &amp; Investor Conference HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (&#8220;FibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it will host an in-person analyst day at the New York Marriott Marquis on February 12, 2025, at 2:00 p.m. ET. The event will feature presentations from the following members of the Company&#8217;s management: Pete O\u2019Heeron, Chief Executive Officer Hamid Khoja, PhD, Chief Scientific Officer Robert Hoffman, Interim Chief Financial Officer The event will highlight FibroBiologics\u2019 research and development strategy for advancing fibroblast-based therapeutics to address &hellip; Continue reading &quot;FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T14:21:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates\",\"datePublished\":\"2025-02-05T14:21:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/\"},\"wordCount\":328,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/\",\"name\":\"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=\",\"datePublished\":\"2025-02-05T14:21:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/","og_locale":"en_US","og_type":"article","og_title":"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates - Market Newsdesk","og_description":"FibroBiologics to also present at the BIO CEO &amp; Investor Conference HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (&#8220;FibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it will host an in-person analyst day at the New York Marriott Marquis on February 12, 2025, at 2:00 p.m. ET. The event will feature presentations from the following members of the Company&#8217;s management: Pete O\u2019Heeron, Chief Executive Officer Hamid Khoja, PhD, Chief Scientific Officer Robert Hoffman, Interim Chief Financial Officer The event will highlight FibroBiologics\u2019 research and development strategy for advancing fibroblast-based therapeutics to address &hellip; Continue reading \"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T14:21:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates","datePublished":"2025-02-05T14:21:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/"},"wordCount":328,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/","name":"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=","datePublished":"2025-02-05T14:21:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzExNSM2NzM2MDkxIzIyNjM1MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-host-in-person-analyst-day-to-provide-research-development-updates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FibroBiologics to Host In-Person Analyst Day to Provide Research &amp; Development Updates"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=809213"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809213\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=809213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=809213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=809213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}